Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement with Australian Distributor TCann Pty Ltd.
STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”)...
Month: August 2021
Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine
Agreement allowing work on numerous collaborative research initiatives in the coming yearsDENVER, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations...
Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products
GOODMIND™ Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products TORONTO and CAPE TOWN, South Africa,...
Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing...
Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on its WTX-124 INDUKINE™ Program
Werewolf Therapeutics to evaluate WTX-124, a systemically-delivered, conditionally activated Interleukin-2 (IL-2) INDUKINE molecule, in combination with KEYTRUDA® (pembrolizumab) as a...
FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients
Expanded Depression Indication Further Demonstrates Company’s Leadership PositionBURLINGTON, Mass. and JERUSALEM, Aug. 18, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ...
Introducing Back Forty 40s: Machine-Rolled, Straight Pre-Rolls with High-Potency Cannabis
Back Forty 40s Package Back Forty 40s recyclable packaging, designed for sharing out of the pack. Back Forty 40s Back...
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil
Completed the regulatory process required to ship medical cannabis to Brazil with import permits issued from ANVISA and export permits...
ProMIS Neurosciences Inc. Announces Pricing of US$15 Million Public Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) --...
AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)
MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...
Cabaletta Bio Reports Clinical Data from the Second Dose Cohort in DesCAARTes™ Trial in Patients with mPV
– No dose-limiting toxicities (DLTs) or clinically relevant adverse events observed as of August 17 using 100 million cells in...
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows Significant Reduction in Seizure Activity
-- BMB proprietary 5-HT2C agonist, BMB-101, shows efficacy in pre-clinical models of Dravet Syndrome/Epilepsy, with lower seizure duration and frequency...
Sharps Compliance Reports Fiscal 2021 Fourth Quarter Results
Fourth Quarter Revenue of $18.7 million and full year 2021 Revenue of $76.4 million, each increased 49% from the prior...
Leading Independent Proxy Advisors ISS and Glass Lewis Support Transaction Between HEXO and Redecan Shareholders, Recommend HEXO Shareholders Vote FOR the Transaction Resolution and Financing Resolution
Leading proxy advisors Institutional Shareholders Services and Glass Lewis recommend HEXO shareholders vote FOR the Transaction Resolution and the Financing...
Coloplast delivers 11% organic growth in Q3 and an EBIT margin of 33%
Organic growth in Q3 was 11% and reported revenue in DKK was up by 9% to DKK 4,835 million. EBIT...
Coloplast A/S – Announcement no. 04/2021 – Interim Financial Report, 9M 2020/21
9M 2020/21Interim financial results, 9M 2020/211 October 2020 - 30 June 2021Coloplast delivered Q3 organic growth of 11% and 33%...
BioPorto Announces Q2 2021 Report
August 18, 2021Announcement no. 14Q2 2021 Report Highlights Solid revenue growth in the first half of 2021 In the first half of...
Allarity Therapeutics Elaborates on the Contents of the Meeting Agenda for the Extraordinary General Meeting Announced on August 16, 2021
Press Release Hørsholm, Denmark (August 18, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) yesterday published a notice to...
Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreement
ORION CORPORATION PRESS RELEASE 18 AUGUST 2021 at 9.00 a.m. EEST Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration...
Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf Region
– Bylvay is approved in the U.S. and EU as only once-daily drug indicated for patients with PFIC – – PFIC is...
